CCI
DEAD

Serial Number

77213446

Owner

Tigenix N.V.

Attorney

Thomas J. Moore

Filing Date

Jun 22, 2007

Add to watchlist:

No watchlists yet
View on USPTO

CCI Trademark

Serial Number: 77213446 • Registration: 3589662

CCI is a trademark filed by Tigenix N.V. on June 22, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Tigenix N.V. (5 trademarks)

Leuven 3001 , BE

Entity Type: 03

Trademark Details

Filing Date

June 22, 2007

Registration Date

March 17, 2009

Published for Opposition

December 30, 2008

Cancellation Date

October 23, 2015

Goods & Services

Pharmaceutical, veterinary or medical preparations for expansion, selection and implantation of human, in vivo, cartilage forming cells; and for controlling the quality of implants before they are implanted into patients; pharmaceutical and medical preparations, namely, nutritious media and substrates for expansion, selection and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for controlling the quality of implants before they are implanted into patients; medical preparations, namely, polymer preparations and cell matrices of any type of origin for expansion, selection and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for controlling the quality of implants before they are implanted into patients; test products for medical use, namely, nucleic acid probes, medical diagnostic reagents, antibodies for the purpose of the control of expansion, selection, and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; hormones and means for the promoting of the growth of cells, namely, so called growth factors for medical use; enzymes for medical use; antibodies for medical use, for the purpose of expansion, selection and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, and for controlling the quality of implants before they are implanted into patients

Preparations for scientific research, namely, nutritious media and substrates for expansion, selection and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for controlling the quality of implants before they are implanted into patients

Pharmaceutical advice; veterinary and medical services; surgical implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical services featuring surgical follow-up

Veterinary or medical devices and instruments, also under the form of kits, for expansion, selection and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for controlling the quality of implants before they are implanted into patients; medical devices and instruments, namely, biopsy kits, implantation kits, quality control kits for expansion, selection and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for controlling the quality of implants before they are implanted into patients

Scientific research, development and study related to expansion, selection, quality control for others and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; laboratory research related to the expansion, selection, quality control for others of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; quality control for others of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; assaying for the purpose of quality control for others of expanded or implanted human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; custom design and development of biochemical assays for the purpose of quality control expanded or implanted human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; scientific research, development and study related to the use of polymer membranes or cell matrices of any type of origin for expansion, selection, quality control for others of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implant; pharmaceutical research services

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 23, 2015 C8..
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 23, 2014 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 23, 2014 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2009 R.PR
PUBLISHED FOR OPPOSITION
Dec 30, 2008 PUBO
NOTICE OF PUBLICATION
Dec 10, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 22, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 22, 2008 GNRN
NON-FINAL ACTION E-MAILED
May 22, 2008 GNRT
NON-FINAL ACTION WRITTEN
May 22, 2008 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 22, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 11, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 1, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2008 CRFA
ASSIGNED TO LIE
Mar 7, 2008 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2007 GNRN
NON-FINAL ACTION E-MAILED
Aug 10, 2007 GNRT
NON-FINAL ACTION WRITTEN
Aug 10, 2007 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2007 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Jun 27, 2007 MDSC
NEW APPLICATION ENTERED
Jun 26, 2007 NWAP